FRIDAY, Feb. 28, 2025 (HealthDay News) — GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded. Earlier research had potentially linked these drugs — which are used to treat type 2 diabetes and obesity — with suicidal thoughts and self-harm,Continue Reading

WEDNESDAY, Feb. 5, 2025 (HealthDay News) — “Yo-yo” dieting — repeatedly losing and gaining weight — can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics with greater weight fluctuations experienced a 40% decline in their kidneys’ ability to filter toxins fromContinue Reading

TUESDAY, Feb. 4, 2025 (HealthDay News) — Canadian youngsters are munching loads of ultra-processed foods, increasing their lifelong risk of obesity, a new study says. “We saw that ultra-processed foods contributed to almost half of a child’s total daily energy intake,” senior researcher Kozeta Miliku, an assistant professor of nutritionalContinue Reading

THURSDAY, Jan. 30, 2025 (HealthDay News) — Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study reports. Patients had a 72% lower risk of developing serious complications of liver disease after undergoing weight-loss surgery, researchers reported in Jan. 27 in theContinue Reading